KYLA NICOLE PRICE
LOS ANGELES, CA
Browse related groups: CA Dermavant Sciences, Inc. All categories
This page merges CMS profile IDs: 11425680, 11435876 (associated profiles published by CMS for the same provider; see the provenance section below).
General Payments — all program years on this page
$2,279.60
- Category: General Payments
- Program years: PY2022–2024
- Record count: 24
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $645.83 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $564.97 | 6 |
| Education | $80.86 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Dermavant Sciences, Inc. | $145.25 | 1 |
| SOBI, INC | $127.50 | 1 |
| GENZYME CORPORATION | $121.41 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $112.27 | 1 |
| Regeneron Healthcare Solutions, Inc. | $80.86 | 1 |
| Galderma Laboratories, L.P. | $30.84 | 1 |
| ABBVIE INC. | $27.70 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1105312855 | ABBVIE INC. | $27.70 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1114140344 | Regeneron Healthcare Solutions, Inc. | $80.86 | 12/18/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1117919175 | Boehringer Ingelheim Pharmaceuticals, Inc. | $112.27 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1127920245 | Dermavant Sciences, Inc. | $145.25 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139743050 | GENZYME CORPORATION | $121.41 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141418334 | SOBI, INC | $127.50 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1145322483 | Galderma Laboratories, L.P. | $30.84 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
- Merged CMS profile IDs: 11425680, 11435876
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.